Influence of initial treatment delay on overall survival and event-free survival in childhood acute lymphoblastic leukemia

Influence of initial treatment delay on overall survival and event-free survival in childhood acute lymphoblastic leukemia

Background Acute lymphoblastic leukemia (ALL) is the most common childhood malignancy. Initial treatment delay is a modifiable prognostic factor that significantly affects overall survival (OS) and event-free survival (EFS) of childhood ALL in high-income countries. Nevertheless, the effect of delay...

Full description

Bibliographic Details
Main Authors:	Irenne Purnama, Pudjo Hagung Widjajanto, Wahyu Damayanti
Format:	Article
Language:	English
Published:	Indonesian Pediatric Society Publishing House 2021-08-01
Series:	Paediatrica Indonesiana
Subjects:	: initial treatment delay; childhood; all overall survival; event free survival
Online Access:	https://paediatricaindonesiana.org/index.php/paediatrica-indonesiana/article/view/2445

Similar Items

The outcomes of childhood acute lymphoblastic leukemia with hyperleukocytosis
by: Din Alfina, et al.
Published: (2018-08-01)

A Nomogram for the Prediction of Progression and Overall Survival in Childhood Acute Lymphoblastic Leukemia
by: Dan Zhang, et al.
Published: (2020-08-01)

Childhood Hodgkin Lymphoma in Iran; survival and outcome
by: Azim Mehrvar, et al.
Published: (2020-09-01)

Shorter maintenance therapy in childhood Acute Lymphoblastic Leukemia. The experience of the prospective, randomized Brazilian GBTLI ALL-93 protocol.
by: Silvia Regina Brandalise, et al.
Published: (2016-10-01)

Survival and prognostic factors of childhood acute lymphoblastic leukemia
by: Emelyana Permatasari, et al.
Published: (2009-12-01)

Nomograms to predict overall survival and cancer-specific survival in patients with adrenocortical carcinoma
by: Li Y, et al.
Published: (2018-12-01)

The Relationship between Immunological Markers, Disease Free Survival and Overall Survival in Acute Myeloid Leukemia in North-West of Iran
by: Zohreh Sanaat, et al.
Published: (2010-12-01)

The Relationship between Immunological Markers, Disease Free Survival and Overall Survival in Acute Myeloid Leukemia in North-West of Iran
by: Zohreh Sanaat, et al.
Published: (2010-10-01)

A Delay from Diagnosis to Treatment is Associated with a Decreased Overall Survival for Patients with Endometrial Cancer
by: Darren eDolly, et al.
Published: (2016-02-01)

Impact of malnutrition on febrile neutropenia in children with acute lymphoblastic leukemia during induction phase chemotherapy
by: Marshalla Agnes, et al.
Published: (2018-12-01)

Nomograms for predicting overall survival and cancer-specific survival in patients with surgically resected intrahepatic cholangiocarcinoma
by: Ma K, et al.
Published: (2019-07-01)

Prognostic nomograms to predict overall survival and cancer‐specific survival in patients with pelvic chondrosarcoma
by: Li Chen, et al.
Published: (2019-09-01)

Nomogram for predicting the overall survival and cancer-specific survival of patients with extremity liposarcoma: a population-based study
by: Lin Ye, et al.
Published: (2020-09-01)

Progression-free survival as a surrogate endpoint of overall survival in patients with metastatic colorectal cancer
by: Cicero G, et al.
Published: (2018-05-01)

Evaluating overall survival and competing risks of survival in patients with early‐stage breast cancer using a comprehensive nomogram
by: Yan‐Bo Xu, et al.
Published: (2020-06-01)

Nomograms predicting the overall survival and cancer-specific survival of patients with stage IIIC1 cervical cancer
by: Yifan Feng, et al.
Published: (2021-04-01)

Nomogram application to predict overall and cancer-specific survival in osteosarcoma
by: Zheng W, et al.
Published: (2018-11-01)

Disease-free survival as a surrogate endpoint for overall survival in adjuvant trials of pancreatic cancer: a meta-analysis of 20 randomized controlled trials
by: Run-Cong Nie, et al.
Published: (2020-05-01)

Competing risk analyses of overall survival and cancer-specific survival in patients with combined hepatocellular cholangiocarcinoma after surgery
by: Chaobin He, et al.
Published: (2019-02-01)

Prognostic factors for progression‐free and overall survival in malignant pleural mesothelioma
by: Jordi Guzmán‐Casta, et al.
Published: (2021-04-01)

Progression-Free Survival Early Assessment is a Robust Surrogate Endpoint of Overall Survival in Immunotherapy Trials of Hepatocellular Carcinoma
by: Giuseppe Cabibbo, et al.
Published: (2021-12-01)

Development and validation of a prognostic nomogram to predict overall survival and cancer-specific survival for patients with anaplastic thyroid carcinoma
by: Weiwei Gui, et al.
Published: (2020-05-01)

A correlation analysis to assess event-free survival as a trial-level surrogate for overall survival in early breast cancer
by: Bishal Gyawali, et al.
Published: (2021-02-01)

Development and validation of Nomograms for predicting overall survival and Cancer-specific survival in patients with ovarian clear cell carcinoma
by: Qian Chen, et al.
Published: (2020-10-01)

Progression-free survival, post-progression survival, and tumor response as surrogate markers for overall survival in patients with extensive small cell lung cancer
by: Hisao Imai, et al.
Published: (2015-01-01)

The correlation between value of tumor markers CA 15-3 and CEA on histopathology grading, metastasis, disease free-survival and overall survival in women with breast cancer
by: Rudy Budijono, Haryasena Haryasena, Prihantono Prihantono, Muhammad Faruk
Published: (2020-12-01)

The expression of Eps15 homology domain 1 is negatively correlated with disease-free survival and overall survival of osteosarcoma patients
by: Hongwei Yu, et al.
Published: (2019-04-01)

Nomogram for individually predicting overall survival in rectal neuroendocrine tumours
by: Xingyu Feng, et al.
Published: (2020-09-01)

3-year survival rate in acute lymphoblastic leukemia: comparison of ALL-2006 and ALL-2013 Protocols
by: Avyandita Meirizkia, et al.
Published: (2021-05-01)

Nomograms to predict 2-year overall survival and advanced schistosomiasis-specific survival after discharge: a competing risk analysis
by: Guo Li, et al.
Published: (2020-05-01)

Impact of cytogenetics on outcomes in pediatric acute lymphoblastic leukemia
by: Rachana Chennamaneni, et al.
Published: (2018-01-01)

Nomograms for Predicting Overall Survival Among Patients with Craniopharyngiomas at Initial Diagnosis: A SEER Population-Based Analysis
by: Teng H, et al.
Published: (2021-07-01)

Epidemiology, diagnostics and long-term overall survival of patients with non-small cell lung cancer in the Brest Region
by: Siarhei Panko, et al.
Published: (2013-10-01)

Advances in the Treatment of Childhood Acute Lymphoblastic Leukemia
by: Hyery Kim
Published: (2019-04-01)

A genomic-clinicopathologic nomogram for predicting overall survival of hepatocellular carcinoma
by: Kena Zhou, et al.
Published: (2020-12-01)

Nomograms for predicting long‐term overall survival and cancer‐specific survival in lip squamous cell carcinoma: A population‐based study
by: Chuan-Yu Hu, et al.
Published: (2019-07-01)

Pathologic-Based Nomograms for Predicting Overall Survival and Disease-Free Survival Among Patients with Locally Advanced Rectal Cancer
by: Liu S, et al.
Published: (2021-02-01)

Anti-HER2 antibody prolongs overall survival disproportionally more than progression-free survival in HER2-Positive metastatic breast cancer patients
by: I-Chun Chen, et al.
Published: (2021-10-01)

A nomogram for predicting overall survival in patients with Ewing sarcoma: a SEER-based study
by: Zhenggang Zhou, et al.
Published: (2020-11-01)

Baseline erectile function and overall survival after radical prostatectomy
by: E. A. Sokolov, et al.
Published: (2020-10-01)